Now showing items 235-254 of 637

      Title
      Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination [1]
      Facemasks: Perceptions and use in an ED population during COVID-19. [1]
      Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series [1]
      A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection. [1]
      Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S. [1]
      Flatten the curve: Empirical evidence on how non-pharmaceutical interventions substituted pharmaceutical treatments during COVID-19 pandemic [1]
      Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment [1]
      The functional consequences of the novel ribosomal pausing site in sars-cov-2 spike glycoprotein rna [1]
      Functional landscape of SARS-CoV-2 cellular restriction [1]
      Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications [1]
      G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19 [1]
      Gastrointestinal and Liver Manifestations of COVID-19 [1]
      Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross [1]
      Genome-wide characterization of SARS-CoV-2 cytopathogenic proteins in the search of antiviral targets. [1]
      Getting Real: The Maryland Healthcare Ethics Committee Network's COVID-19 Working Group Debriefs Lessons Learned [1]
      Ghana's COVID-19 response: the Black Star can do even better [1]
      Giving birth during the COVID-19 pandemic, perspectives from a sample of the United States birthing persons during the first wave: March-June 2020 [1]
      Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic [1]
      Going Virtual: Redesigning the Interview Experience [1]
      The Goldilocks Time for Remdesivir - Is Any Indication Just Right? [1]